Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 2.21x is 680% above its 5-year average of 0.28x, near the high end of its 5-year range (-35.19x–4.70x).
27.74% below its 12-month average of 3.06x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-27): 4.70x.
INTEREST COVERAGE RATIO
2.21x
INTEREST COVERAGE RATIO AVG TTM
3.06x
INTEREST COVERAGE RATIO AVG 3Y
1.28x
INTEREST COVERAGE RATIO AVG 5Y
0.28x
INTEREST COVERAGE RATIO AVG 10Y
0.79x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-27.74%
CURRENT VS 3Y AVG
+73.21%
CURRENT VS 5Y AVG
+680.12%
CURRENT VS 10Y AVG
+179.66%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 292 covered companies
CURRENT VS SECTOR MEDIAN
+174.29%
vs the sector median at left
Bioventus Inc.
Market Cap
$915.95M
Interest Coverage Ratio
2.21x
TTM Avg
3.06x
3Y Avg
1.28x
5Y Avg
0.28x
Market Cap
$921.45M
Interest Coverage Ratio
N/A
TTM Avg
204.36x
3Y Avg
142.82x
5Y Avg
142.82x
Market Cap
$922.50M
Interest Coverage Ratio
-278.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$903.13M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$943.26M
Interest Coverage Ratio
-30.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$867.60M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$852.55M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$985.79M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bioventus Inc. (BVS) | $915.95M | 2.21x | 3.06x | 1.28x | 0.28x |
| HealthStream, Inc. (HSTM)vs › | $921.45M | N/A | 204.36x | 142.82x | 142.82x |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | -278.88x | N/A | N/A | N/A |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | N/A | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $943.26M | -30.90x | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | N/A | N/A | N/A | N/A |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | N/A | N/A | N/A | N/A |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | N/A | N/A | N/A | N/A |
| Alumis Inc. (ALMS)vs › | $844.28M | N/A | N/A | N/A | N/A |
Interest Coverage
2.2x
Debt/Equity
1.16
Current Ratio
1.69
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-27 | 4.70x |
| 2026-03-28 | 2.05x |
| 2025-12-31 | 4.09x |
| 2025-09-27 | 1.96x |
| 2025-06-28 | 2.48x |
| 2025-03-29 | 0.66x |
| 2024-12-31 | 0.89x |
| 2024-09-28 | 0.43x |
| 2024-06-29 | -3.17x |
| 2024-03-30 | 0.48x |
| 2023-12-31 | 0.11x |
| 2023-09-30 | 0.24x |
| 2023-07-01 | 0.64x |
| 2023-04-01 | -9.50x |
| 2022-12-31 | -1.71x |
| 2022-10-01 | -35.19x |
| 2022-07-02 | -1.28x |
| 2021-12-31 | -3.28x |
| 2021-10-02 | -0.78x |
| 2021-07-03 | -3.41x |
| 2020-12-31 | 2.22x |
| 2020-09-30 | 3.69x |
| 2020-06-30 | -1.62x |
| 2020-03-28 | 5.46x |
| 2019-12-06 | 1.79x |
| 2019-12-06 | 2.33x |
| 2016-03-31 | -0.57x |
| 2015-03-31 | -4.23x |
